메뉴 건너뛰기




Volumn 4, Issue 3, 2010, Pages 132-138

High prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a tertiary care hospital in Tehran, Iran

Author keywords

Beta lactamases; Enterobacteriaceae; ESBL; Klebsiella pneumoniae; Nosocomial infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE;

EID: 77951154336     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.488     Document Type: Article
Times cited : (42)

References (25)
  • 1
    • 33646837531 scopus 로고    scopus 로고
    • Resistance in Gram-negative bacteria: Enterobacteriaceae
    • Paterson DL (2006) Resistance in Gram-negative bacteria: Enterobacteriaceae. Am J Med 119: S20-28.
    • (2006) Am J Med , vol.119
    • Paterson, D.L.1
  • 2
    • 0037333487 scopus 로고    scopus 로고
    • Extended-spectrum β-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals
    • Tzelepi E, Magana Ch, Platsouka E, Sofianu D, Paniara O, Legakis NJ et al. (2003) Extended-spectrum β-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. Int J Antimicrob Agents 21: 285-288.
    • (2003) Int J Antimicrob Agents , vol.21 , pp. 285-288
    • Tzelepi, E.1    Magana, C.2    Platsouka, E.3    Sofianu, D.4    Paniara, O.5    Legakis, N.J.6
  • 3
    • 24744448199 scopus 로고    scopus 로고
    • Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998- 2002)
    • Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y et al. (2005) Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998- 2002). Diagn Microbiol Infect Dis 52: 323-329.
    • (2005) Diagn Microbiol Infect Dis , vol.52 , pp. 323-329
    • Hirakata, Y.1    Matsuda, J.2    Miyazaki, Y.3    Kamihira, S.4    Kawakami, S.5    Miyazawa, Y.6
  • 4
    • 33750959806 scopus 로고    scopus 로고
    • Antibiotic-resistance patterns and frequency of extended-spectrum β-lactamase- producing isolates of Klebsiella pneumoniae in Tehran
    • Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, Bokaei S (2006) Antibiotic-resistance patterns and frequency of extended-spectrum β-lactamase- producing isolates of Klebsiella pneumoniae in Tehran. Med Sci Monit 12: BR362-365.
    • (2006) Med Sci Monit , vol.12
    • Feizabadi, M.M.1    Etemadi, G.2    Yadegarinia, D.3    Rahmati, M.4    Shabanpoor, S.5    Bokaei, S.6
  • 6
    • 0003358488 scopus 로고    scopus 로고
    • Performance standards for antimicrobial susceptibility testing
    • National Committee for Clinical Laboratory Standards (NCCLS), Wayne, PA: NCCLS
    • National Committee for Clinical Laboratory Standards (NCCLS) (2004) Performance standards for antimicrobial susceptibility testing. Fourteenth Informational Supplement. Document M100-S14. Wayne, PA: NCCLS.
    • (2004) Fourteenth Informational Supplement. Document M100-S14
  • 7
    • 77951151831 scopus 로고    scopus 로고
    • In vitro activity of imipenem, cefepime and ceftriaxone against common Gram-negative bacilli causing nosocomial infections
    • P447
    • Mehrgan H, Rahbar M (2006) In vitro activity of imipenem, cefepime and ceftriaxone against common Gram-negative bacilli causing nosocomial infections. Iranian J Pharm Sci 2: 247 (P447).
    • (2006) Iranian J Pharm Sci , pp. 2
    • Mehrgan, H.1    Rahbar, M.2
  • 8
    • 0035873724 scopus 로고    scopus 로고
    • Variations in the prevalence of strains expressing an extended-spectrumβ-lactamasephenotypeand characterization of isolates from Europe, the Americas, and the Western Pacific region
    • Winokur PL, Canton R, Casellas JM, Legakis N (2001) Variations in the prevalence of strains expressing an extended-spectrumβ-lactamasephenotypeand characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 32: S94-S103.
    • (2001) Clin Infect Dis , vol.32
    • Winokur, P.L.1    Canton, R.2    Casellas, J.M.3    Legakis, N.4
  • 9
    • 21844435993 scopus 로고    scopus 로고
    • Prevalence and antimicrobial susceptibility of extended-spectrum β- lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital
    • Kader AA and Kumar A (2005) Prevalence and antimicrobial susceptibility of extended-spectrum β- lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med 25: 239-242.
    • (2005) Ann Saudi Med , vol.25 , pp. 239-242
    • Kader, A.A.1    Kumar, A.2
  • 10
    • 0043016377 scopus 로고    scopus 로고
    • Prevalence and susceptibility patterns of extended-spectrum betalactamase- producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut
    • Daoud Z and Hakime N (2003) Prevalence and susceptibility patterns of extended-spectrum betalactamase- producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon. Rev Esp Quimioterap 16: 233-238.
    • (2003) Lebanon. Rev Esp Quimioterap , vol.16 , pp. 233-238
    • Daoud, Z.1    Hakime, N.2
  • 11
    • 3342884472 scopus 로고    scopus 로고
    • Determining incidence of extended spectrum β-lactamase producingEnterobacteriaceae,vancomycin-resistant Enterococcusfaeciumandmethicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: The PEARLS study 2001-2002
    • Bouchillon SK, Johnson BM, Hoban DJ, Johnson JL, Dowzicky MJ, Wu DH, Visalli MA, Bradford PA (2004) Determining incidence of extended spectrum β-lactamase producingEnterobacteriaceae,vancomycin-resistant Enterococcusfaeciumandmethicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int J Antimicrob Agents 24: 119-124.
    • (2004) Int J Antimicrob Agents , vol.24 , pp. 119-124
    • Bouchillon, S.K.1    Johnson, B.M.2    Hoban, D.J.3    Johnson, J.L.4    Dowzicky, M.J.5    Wu, D.H.6    Visalli, M.A.7    Bradford, P.A.8
  • 13
    • 0037234746 scopus 로고    scopus 로고
    • Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv medical center (Israel) and evaluation of diagnostic tests
    • Navon-Venezia S, Hammer-Munz O, Schwartz D, Turner D, Kuzmenko B, Carmeli Y (2003) Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv medical center (Israel) and evaluation of diagnostic tests. J Clin Microbiol 41: 155-158.
    • (2003) J Clin Microbiol , vol.41 , pp. 155-158
    • Navon-Venezia, S.1    Hammer-Munz, O.2    Schwartz, D.3    Turner, D.4    Kuzmenko, B.5    Carmeli, Y.6
  • 15
    • 0033966258 scopus 로고    scopus 로고
    • High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum β-lactam drugs in intensive care units
    • Shehabi AA, Mahafzah A, Baadran I, Qadar FA, Dajani N (2000) High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum β-lactam drugs in intensive care units. Diagn Microbiol Infect Dis 36: 53-56.
    • (2000) Diagn Microbiol Infect Dis , vol.36 , pp. 53-56
    • Shehabi, A.A.1    Mahafzah, A.2    Baadran, I.3    Qadar, F.A.4    Dajani, N.5
  • 16
    • 31344468548 scopus 로고    scopus 로고
    • Frequency and sensitivity pattern of Extended Spectrum Beta Lactamase producing isolates in a tertiary care hospital laboratory of Pakistan
    • Jabeen K, Zafar A, Hasan R (2005) Frequency and sensitivity pattern of Extended Spectrum Beta Lactamase producing isolates in a tertiary care hospital laboratory of Pakistan. J Pak Med Assoc 55: 436-439.
    • (2005) J Pak Med Assoc , vol.55 , pp. 436-439
    • Jabeen, K.1    Zafar, A.2    Hasan, R.3
  • 17
    • 0036526633 scopus 로고    scopus 로고
    • Prevalence of extended spectrum β-lactamase producing Gram-negative bacteria in a tertiary care hospital
    • Mathur P, Kapil A, Das B, Dhawan B (2002) Prevalence of extended spectrum β-lactamase producing Gram-negative bacteria in a tertiary care hospital. Indian J Med Res 115: 153-157.
    • (2002) Indian J Med Res , vol.115 , pp. 153-157
    • Mathur, P.1    Kapil, A.2    Das, B.3    Dhawan, B.4
  • 18
    • 21744434393 scopus 로고    scopus 로고
    • Multidrug resistance in Gram- negative bacteria that produce extended-spectrum β-lactamases (ESBLs)
    • Giamarellou H (2005) Multidrug resistance in Gram- negative bacteria that produce extended-spectrum β-lactamases (ESBLs). Clin Microbiol Infect 11: 1-16.
    • (2005) Clin Microbiol Infect , vol.11 , pp. 1-16
    • Giamarellou, H.1
  • 19
    • 0027932406 scopus 로고
    • Detection of resistance due to inducible β-lactamase in Enterobacter aerogenes and Enterobacter cloacae
    • Huber TW, Thomas JS (1994) Detection of resistance due to inducible β-lactamase in Enterobacter aerogenes and Enterobacter cloacae. J Clin Microbiol 32: 2481-2486.
    • (1994) J Clin Microbiol , vol.32 , pp. 2481-2486
    • Huber, T.W.1    Thomas, J.S.2
  • 20
    • 18844482814 scopus 로고    scopus 로고
    • Prevalence of extended spectrum beta-lactamase(ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: Regional results from SENTRY antimicrobial surveillance program (1998-99)
    • the SENTRY APAC Study Group
    • Bell JM, Turnidge JD, Gales AC, Pfaller MA, Jones RN, the SENTRY APAC Study Group (2002) Prevalence of extended spectrum beta-lactamase(ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY antimicrobial surveillance program (1998-99). Diagn Microbiol Infect Dis 42: 193-198.
    • (2002) Diagn Microbiol Infect Dis , vol.42 , pp. 193-198
    • Bell, J.M.1    Turnidge, J.D.2    Gales, A.C.3    Pfaller, M.A.4    Jones, R.N.5
  • 21
    • 24044435593 scopus 로고    scopus 로고
    • Risk factors associated with extended-spectrum β-lactamase-producing organisms at a tertiary care hospital
    • Graffunder EM, Preston KE, Evans AM, Venezia A (2005) Risk factors associated with extended-spectrum β-lactamase-producing organisms at a tertiary care hospital. J Antimicro Chemother 56: 139-145.
    • (2005) J Antimicro Chemother , vol.56 , pp. 139-145
    • Graffunder, E.M.1    Preston, K.E.2    Evans, A.M.3    Venezia, A.4
  • 22
    • 0141928012 scopus 로고    scopus 로고
    • Extended-spectrum β lactamase-producing Klebsiella pneumoniae infections: A review of the literature
    • Gupta A, Ampofo K, Rubenstein D, Saiman L (2003) Extended-spectrum β lactamase-producing Klebsiella pneumoniae infections: a review of the literature. J Perinatol 23: 439-443.
    • (2003) J Perinatol , vol.23 , pp. 439-443
    • Gupta, A.1    Ampofo, K.2    Rubenstein, D.3    Saiman, L.4
  • 23
    • 33646545027 scopus 로고    scopus 로고
    • The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors
    • Ozgunes I, Erben N, Kiremitci A, Kartal ED, Durmaz G, Colak H, Usluer G, Colak E. (2006) The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors. Saudi Med J 27: 608-612.
    • (2006) Saudi Med J , vol.27 , pp. 608-612
    • Ozgunes, I.1    Erben, N.2    Kiremitci, A.3    Kartal, E.D.4    Durmaz, G.5    Colak, H.6    Usluer, G.7    Colak, E.8
  • 24
    • 0043028335 scopus 로고    scopus 로고
    • Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum β-lactamase in Europe
    • MYSTIC Study Group (Europe)
    • Jones RN, Pfaller MA, MYSTIC Study Group (Europe) (2003) Antimicrobial activity against strains of Escherichia coli and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum β-lactamase in Europe. Clin Microbiol Infect 9: 708-712.
    • (2003) Clin Microbiol Infect , vol.9 , pp. 708-712
    • Jones, R.N.1    Pfaller, M.A.2
  • 25
    • 0031930453 scopus 로고    scopus 로고
    • Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates
    • Pillary T, Pillary DG, Adhikari M, Sturm AW (1998) Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates. AM J Perinatol 15: 47-51.
    • (1998) AM J Perinatol , vol.15 , pp. 47-51
    • Pillary, T.1    Pillary, D.G.2    Adhikari, M.3    Sturm, A.W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.